Newsletter | Venue | Contact

Conference and Matchmaking Location: Konzil Konstanz*
Conference Language: English

Day 1, October 25, 2021

Programme October 25, 2021

12.00

Pre-conference special:
Matchmaking event with 1-to-1 meetings (only a limited number of tickets available!)

15.30

Registration, welcome coffee, exhibition & networking

16.00

Welcome and introduction by BioLAGO

Session 1: Digital diagnostics - what are valid business models?

Chair: Dr. Michael Steinwand, BioLAGO / Innovendia Consulting Services (D)

16.10

Keynote
Added value through digital health and related business models
Sebastian Vorberg, Bundesverband Internetmedizin (Federal Association Internet Medicine)

16.35

Networking and exhibition

17.00

Digital approaches to ensure continuity and quality in cancer treatment
Bastian Hennig, Roche Diagnostics Deutschland GmbH (D)

17.20

Digital health - viable models from the perspective of medium-sized enterprises
Alexander Gmelin, VidaWell GmbH (D)

17.40

Plenary discussion

17.50

Networking and exhibition

18.30

Conference Dinner (Location: Steigenberger Inselhotel)

Day 2, October 26, 2021

Programme October 26, 2021

09.30

Registration, welcome coffee & networking

10.00

Introduction and review of Day 1:
Dr. Michael Steinwand, BioLAGO (D)

Session 2: New diagnostic concepts for infectious diseases

Chair: Dr. Daniel Caminada, LMZ Dr Risch Group (LI/CH)

10.05

Keynote
Looking Beyond PCR: Novel Applications of Molecular Diagnostics to Detect Secondary Bacterial Infections in Patients with Influenza or SARS-CoV-2
Dr. med. Peter Keller, University Hospital of Bern ‘Inselspital‘ (CH)

10.30

Whole genome sequencing of pathogens for infection surveillance

Dr. Oliver Nolte, Center for Laboratory Medicine St. Gallen (CH)

10.50

A microfluidics platform in combination with NGS for ultra-fast notification of Mycobacterium tuberculosis and its resistance pattern
Dr. Harald Hoffmann, Institute of Microbiology and Laboratory Medicine (D)
Dr. Kerstin Rönsch, Eurofins Genomics Europe Sequencing GmbH (D)

11.10

Decoding the Unknown: Use of Clinical Metagenomics to Effectively Diagnose Infectious Diseases
Prof. Dr. John Rossen, University of Groningen (NL)

11.30

Plenary discussion

11.40

Conference lunch & networking

Session 3: Individual diagnostics - the key factor for immunotherapies in cancer treatment

Chair: Dr. Simone Günther, EMC² Lake Constance / Becton Dickinson (D)

13.00

KEYNOTE

Cell therapy and the role of diagnostics - review on up-to-date research
Dr. Reuben Benjamin, King's College London (UK)

13.25

Disease-specific T-cell monitoring – a tool to improve cancer immunotherapies
Dr. Lieselotte Brix, Immudex ApS (DK)

13.45

Deep sequencing: needs & challenges from laboratory view
Dr. Sabine Kelkenberg, CeGaT GmbH (D)

14.05

nanoLabelling for stem cell visualization and tracking
Marc Masa, LEITAT Technological Center (ESP)

14.25

Plenary discussion

14.35

Networking, coffee & exhibition

Session 4: Common diseases - needs and new approaches for diagnostics and therapy

Chair: Dr. Emmanuel Delamarche, IBM Research (CH)

15.15

Keynote
Point of Care versus Lab Based testing of common diseases – Striking a balance
Dr. Stephen G. Maher, Trinity College Dublin, St. James’s Hospital, (IRL)

15.40

Panel discussion
Healthcare in 2025: everything digital?

Introductory presentation:
Future solutions integrating diagnostics and therapy
Dr. Emmanuel Delamarche, IBM Research (CH)

  • Prof. Dr. Peter Turecek, Takeda Pharmaceutical Company Limited (A)
  • Till Osswald, Connected Health (D)
  • Dr. Stephen G. Maher, Trinity College Dublin, St.James's Hospital (IRL)
  • Dr. Ina Wüstefeld, Aesculap AG (D)
  • Dr. med. Volker Liebenberg, Illumina, Inc. (D)
  • Prof. Dr. Ralf Seepold, HTWG Konstanz - University of Applied Sciences (D)

16.40

Closing remarks and networking apéro

*The Conference will take place physically ensuring a safe participation during the coronavirus pandemic. Please note that participation in the event is only possible with a valid COVID certificate (recovered, vaccinated, PCR-tested). For participants who are not vaccinated or recovered, we offer PCR tests for SARS-CoV-2 on-site on the first conference day, October 25, 2021, at 8:00 am. Previous registration for the test is required. For more information, please see our full Hygiene and Safety Measures.